← Eichor
Condition: Non Familial Hypercholesterolemia And Mixed Hyperlipidemia Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Non Familial Hypercholesterolemia And Mixed Hyperlipidemia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

IBI306 Monotherapy in Non-Familial Hypercholesterolemia and Mixed Hyperlipidemia
Phase 3 · 1 location(s) · Innovent Biologics (Suzhou) Co. Ltd. · NCT07473960Phase 3 Clinical Study Evaluating Efficacy, Safety, and Tolerability of Obicetrapib Vs Bempedoic Acid to Treat Dyslipide
Phase 3 · 1 location(s) · A. Menarini International Licensing S.A. · NCT07614958A Study to Evaluate the Safety, Efficacy of SYH2053 as Monotherapy in Chinese Participants With Non-familial Hypercholes
Phase 3 · 2 location(s) · CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. · NCT07421297
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.